Alzheon Garners $4,294,629 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bf0746e7-2ee1-499d-95d1-cbcbae84b638 - Date
2/26/2015 - Company Name
Alzheon - Mailing Address
111 Speen Street Framingham, MA 01701 USA - Company Description
Alzheon is a clinical-stage biotechnology company focused on brain health, memory and aging, developing innovative treatments for Alzheimer’s disease and other neurodegenerative disorders. - Website
http://www.alzheon.com - Transaction Type
Venture Equity - Transaction Amount
$4,294,629 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing – amended. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
